- $51.06bn
- $47.18bn
- $2.19bn
- 62
- 14
- 96
- 59
Annual income statement for argenx SE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 41.2 | 497 | 411 | 1,226 | 2,190 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 381 | 1,108 | 1,963 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 519 | 846 | 1,131 | 1,651 | 2,212 |
| Operating Profit | -478 | -349 | -720 | -425 | -21.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -605 | -400 | -729 | -304 | 85.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -608 | -408 | -710 | -295 | 833 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -608 | -408 | -710 | -295 | 833 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -608 | -408 | -710 | -295 | 833 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -13.4 | -7.99 | -13 | -5.16 | 12.8 |
| Dividends per Share |